source
- Biopharma hiring gaps: experts cite four key mismatches between companies and candidatesRecruiting specialists highlighted persistent disconnects between biopharma employers and job seekers, noting that misaligned expectations can slow hiring and discourage talent. One major issue st…
- FDA grants early approval to RevMed's pancreatic cancer drug RasonqueFDA granted early approval to Revolution Medicines' daraxonrasib, now named Rasonque, for pancreatic adenocarcinoma, arriving 6.5 months before the FDA deadline. The oral RAS inhibitor demonstrate…